DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.17, $0.27 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $266.7 million versus the consensus estimate of $241.3 million.

“Dexcom has maintained the strong momentum we have seen all year, with sales up 45% on a constant currency basis,” said Kevin Sayer, Dexcom’s Chairman, President and CEO. “Clearly, our G6 launch has been very well received and leaves us in a strong position for continued growth. We are pleased to again increase our 2018 outlook.”

GUIDANCE:

DexCom sees FY2018 revenue of $975 million, versus the consensus of $930.83 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.